Axios Pro Rata: Disney divests | Axios Pro Rata Summary

1. Key Themes

Theme 1: Legacy Media's Accelerating Pivot to Streaming

Disney's $1.2B sale of its A+E stake to Hearst is emblematic of a broader strategic realignment away from profitable-but-stagnant cable assets toward streaming-first business models. This is not a one-off transaction but a deliberate portfolio reshaping.

"Disney has been reshaping itself around streaming for years. Its new leadership wants to turn Disney+ into a super app to take on Netflix, and cable stakes that throw off cash but little growth do not fit that story." — Ana Maria Constantin, TNW

Disney simultaneously announced a content partnership with TikTok and used proceeds to increase share buybacks from $8B to at least $9B — signaling capital reallocation, not just divestiture.

Theme 2: AI Infrastructure Is the Dominant Venture Investment Category

The largest venture rounds in this issue are concentrated in AI cloud and AI-adjacent infrastructure. Volta Infra (Singapore-based AI cloud) raised $300M at a $2.4B valuation with an additional $5B in financing, backed by a16z, Altimeter, Nvidia, and Michael Dell. This signals that sovereign and institutional capital continues to chase AI compute capacity globally.

"Volta Infra, a Singaporean AI cloud company, raised $300m at a $2.4b valuation and secured an additional $5b in financing. A16z and Altimeter Capital led, joined by Nvidia, Michael Dell, and Azora."

Theme 3: Private Markets Compensation Is Falling Behind — A Structural Warning Sign

After more than a decade of outperformance, private market professionals are seeing bonus compression just as public market bankers are thriving. This divergence signals a cyclical or structural stress point in private markets that may affect talent retention and fund formation.

"Bonuses are projected to be flat for those in real estate and at small PE and VC firms. Private credit bonus growth is projected to be flat to negative 10%... Private markets have led the pack for more than a decade. The reversal this year is a 'seismic change,' Johnson says."

Theme 4: Defense Tech and Dual-Use Investment Continues to Deepen

Private equity's involvement in defense tech is deepening beyond early-stage VC. Former U.S. Army General James Rainey joining Bain Capital as a senior advisor is a signal of institutional PE doubling down on defense relationships, not just deal flow.

"It's a reminder that private equity continues to play a major role in defense-tech, as it has for decades, even if most of the PR heat is at the earlier stages."

Theme 5: Nuclear Fusion Attracting Institutional Capital

Commonwealth Fusion Systems secured $1B in new funding, with CalPERS — one of the largest public pension funds in the U.S. — identified as a major new investor. This is a notable signal: pension capital moving into frontier energy bets.

"Commonwealth Fusion Systems, a Devens, Mass.-based nuclear fusion startup, last week announced $1 billion in new funding without identifying any investors. Multiple sources tell me that CalPERS is a major new investor in the company."

2. Contrarian Perspectives

Contrarian 1: Pfizer's $10B GLP-1 Oral Bet Was Structurally Flawed from the Start

The acquisition of Metsera was framed as a major move into the obesity drug market, with Pfizer hyping oral GLP-1 candidates as "a differentiated set of assets" that could be "cheaper and more tolerable." Yet Pfizer has now scrapped the oral candidate — a surprise reversal that reveals the deal's earnout structure never actually supported the oral thesis.

"Orals weren't part of the $2.3 billion of CVR payments within the Metsera buyout. Instead, those earnouts are tied to injectables."

The implication: investors and observers who evaluated the Metsera deal based on the oral drug narrative were tracking the wrong asset. The real value was always in the injectable pipeline — making the hyped oral framing potentially misleading from day one.

Contrarian 2: Open AI Models May Escape Regulatory Scrutiny by Design

The White House plans to exclude open models from its advanced AI capability testing framework. This is a meaningful regulatory carve-out that could have outsized competitive implications — allowing open-source AI development to accelerate without the compliance burden faced by closed-model providers like OpenAI and Anthropic.

"The White House plans to exclude open models from its framework to test advanced AI capabilities."

This could structurally advantage open-model ecosystems and companies building on top of them, while creating a compliance moat headache for closed-model incumbents.

Contrarian 3: Direct Secondaries in VC Are Gaining a Structural Edge Through LP Network Effects

Revenant VC's debut fund is being built on a novel LP structure — dozens of GPs at other VC firms — which creates an informational and deal-sourcing advantage that traditional LPs cannot replicate. This suggests that the most defensible secondaries strategies may no longer be about scale, but about insider access.

"The strategy is direct secondaries — primary, not strips — partially enabled by an LP base that includes dozens of GPs at other venture firms."

3. Companies Identified

Disney (NYSE: DIS) Major media and entertainment conglomerate. Mentioned as the seller of its 50% stake in A+E Global Media for $1.2B to Hearst, as part of its ongoing restructuring toward streaming.

"Disney keeps cutting its legacy cable cords — mirroring its customers — even if that means losing a profitable business and deep content library."

A+E Global Media Cable media company owning History and Lifetime channels. Central to the Disney-Hearst deal; reaches 414M+ households.

"A+E says its channels, including History and Lifetime, reach more than 414 million households in 200 territories in 40 languages."

Commonwealth Fusion Systems Devens, Mass.-based nuclear fusion startup. Raised $1B in new funding; CalPERS identified as a major new investor.

"Multiple sources tell me that CalPERS is a major new investor in the company."

Volta Infra Singapore-based AI cloud company. Raised $300M at $2.4B valuation plus $5B in additional financing; led by a16z and Altimeter Capital with Nvidia and Michael Dell participating.

"Volta Infra, a Singaporean AI cloud company, raised $300m at a $2.4b valuation and secured an additional $5b in financing."

Moove UAE-based autonomous mobility startup. Raised $250M Series C at a $2.1B valuation; led by Mubadala with Toyota and Woven Capital.

"Moove, a UAE-based autonomous mobility startup, raised $250m in Series C funding at a $2.1b valuation."

Decade Brazilian AI wealth advisor. Raised an unusually large $85M seed round from Greenoaks, Benchmark, and Diffusion — notable for seed-stage scale.

"Decade, a Brazilian AI wealth advisor, raised $85m in seed funding from Greenoaks, Benchmark and Diffusion."

Expedition Therapeutics SF-based developer of oral therapies for inflammatory and respiratory diseases. Raised $115M Series B led by General Atlantic with a broad institutional syndicate.

"Expedition Therapeutics, an SF-based developer of oral therapies for inflammatory and respiratory diseases, raised $115m in Series B funding."

Electronic Arts Major video game publisher, now private. Completed its $55B buyout by Saudi Arabia's Public Investment Fund, Silver Lake, and Affinity Partners.

"Electronic Arts is now a private company, after completing its $55b buyout by Saudi Arabia's Public Investment Fund, Silver Lake, and Affinity Partners."

Pfizer Global pharmaceutical giant. Scrapped an oral GLP-1 candidate from its $10B Metsera acquisition, despite prior bullish framing.

"Pfizer had hyped the upside of Metsera's oral drugs as a 'differentiated set of assets' that could be cheaper and more tolerable than other oral GLP-1s."

Procter & Gamble (NYSE: PG) Consumer goods conglomerate. Agreed to acquire supplements maker Thorne for $3.8B from L Catterton — a major consumer health bet.

"Procter & Gamble agreed to buy supplements maker Thorne for $3.8b from L Catterton."

Hinge Health (NYSE: HNGE) Digital musculoskeletal health company. Acquiring Cylinder Health (digestive health) for $105M, expanding its platform beyond MSK.

"Hinge Health agreed to acquire digestive health startup Cylinder Health for $105m in cash."

SpaceX Aerospace and space transport company. Reported higher-than-expected post-IPO revenue, but shares fell sharply, likely tied to AI spending concerns and upcoming lockup expiration.

"SpaceX reported higher-than-expected revenue in its post-IPO earnings report. Shares today are sharply lower, perhaps due to investor concerns about AI spend, ahead of tomorrow's first big lockup expiration."

Revenant VC New debut venture fund led by Ryan Moore (ex-Accomplice). Raised $78M first close; strategy focuses on direct secondaries, backed by GP LPs at other VC firms.

"The strategy is direct secondaries — primary, not strips — partially enabled by an LP base that includes dozens of GPs at other venture firms."

G Squared Direct secondaries firm. Raised $2.3B for its seventh flagship fund — a significant data point on institutional appetite for secondaries.

"G Squared, a direct secondaries firm, raised $2.3b for its seventh flagship fund."

Monolith Management Hong Kong-based VC firm (backed Moonshot). Raising $500M for a fund focused on Chinese AI — notable given geopolitical context.

"Monolith Management, a Hong Kong-based VC firm that backed Moonshot, is raising $500m for a fund focused on Chinese AI."

AiDash Palo Alto-based utility asset monitoring platform. Acquired by Schneider Electric for $350M after raising only $91.5M in VC — a strong multiple outcome.

"Schneider Electric agreed to acquire AiDash, a Palo Alto, Calif.-based utility asset monitoring provider, for $350m in cash."

Throne Science Austin, Texas-based maker of AI toilet sensors. Raised $10M Series A led by Will Ventures, backed by Emerson Collective. Unusual but notable for AI-in-health-monitoring category.

"Throne Science, an Austin, Texas-based maker of AI toilet sensors, raised $10m in Series A funding."

4. People Identified

Ryan Moore Former partner at Accomplice VC, now founder/GP of Revenant VC. Mentioned for launching a debut $78M direct secondaries fund with a novel GP LP base.

"Revenant VC, led by Ryan Moore (ex-Accomplice), has held a $78 million first close on its debut fund... Moore's best-known deal at Accomplice was an early check for DraftKings, where he's still on the board of directors."

Blake Masters Former Thiel Capital COO; ran unsuccessful Arizona Senate and House campaigns. Now raising up to $150M for Industrial Capital Fund, with Brian Norgard (ex-Tinder CPO) as partner.

"He's raising up to $150 million for a new effort called Industrial Capital Fund... His partner is Brian Norgard, former chief product officer at Tinder."

Brian Norgard Former Chief Product Officer at Tinder. Co-founder of Blake Masters' Industrial Capital Fund.

"His partner is Brian Norgard, former chief product officer at Tinder."

General James Rainey Former commanding general of the U.S. Army's Futures Command. Joining Bain Capital as a senior advisor, reinforcing PE's sustained interest in defense-tech.

"Former U.S. Army General James Rainey, who last served as commanding general of the Army's Futures Command, is said to be joining Bain Capital as a senior advisor."

5. Operating Insights

Insight 1: Structure Your M&A Earnouts Around Your Core Thesis — Not the Upside Story

Pfizer's Metsera deal illustrates a critical operating lesson: the public-facing rationale (oral GLP-1 drugs) and the actual earnout structure (tied to injectables) were misaligned. When the oral candidate failed, Pfizer had no financial incentive mechanism to protect it — and no CVR payments were at risk. Entrepreneurs and acquirers alike should ensure deal structures reinforce — not contradict — stated strategic rationale.

"Orals weren't part of the $2.3 billion of CVR payments within the Metsera buyout. Instead, those earnouts are tied to injectables."

Insight 2: Build LP Networks That Double as Deal Networks

Revenant VC's structure — an LP base composed of dozens of GPs at other VC firms — is a deliberate strategy to create proprietary deal flow in direct secondaries. This is a model other emerging managers should study: your LP base can be a competitive moat, not just a capital source.

"The strategy is direct secondaries — primary, not strips — partially enabled by an LP base that includes dozens of GPs at other venture firms."

Insight 3: Capital Recycling via Divestitures Can Fund Aggressive Return-of-Capital Programs

Disney's sale of A+E for $1.2B directly funded a $1B increase in its share buyback target. For operators managing complex portfolios, asset sales from non-core divisions can be a surgical tool to accelerate capital return without taking on new leverage.

"Disney...says the sale will help it boost upcoming share buybacks to at least $9 billion from $8 billion."

6. Overlooked Insights

Overlooked Insight 1: Sovereign and State Pension Capital Is Now Backing Frontier Energy at Scale

CalPERS — a pension fund with fiduciary obligations to California public employees — is a "major new investor" in Commonwealth Fusion Systems, a pre-revenue nuclear fusion company. This represents a meaningful shift in what institutional capital considers an acceptable risk profile, and may signal that other large LPs will follow into deep-tech energy bets previously reserved for specialist or family office capital.

"Multiple sources tell me that CalPERS is a major new investor in the company."

Overlooked Insight 2: Walmart Is Building a Streaming Ad Infrastructure Through M&A

Walmart's completed acquisition of VibeCo — a streaming ad platform that had raised nearly $80M — is a quiet but strategically significant move. It positions Walmart to monetize its retail media network through streaming inventory, competing with Amazon's ad business on its own terms. This deal received minimal emphasis in the newsletter but could represent a major strategic inflection for retail media.

"Walmart completed its purchase of VibeCo, a streaming ad platform that had raised nearly $80m from firms like Hedosophia, Revolut, Elaia and Singular."